Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 0.35 |
| ▸ | POLA1 | P09884 | 1/20 | 0.35 |
| ▸ | POLG | P54098 | 1/20 | 0.35 |
| ▸ | FAP | Q12884 | 1/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4415990 | 0.90 | ABCB11 (0.40) | ABCB11POLA1POLGFAPSLC22A6 | |
| SCHEMBL4419762 | 0.90 | ABCB11 (0.40) | ABCB11POLA1POLGFAPSLC22A6 | |
| SCHEMBL2912291 | 0.90 | ABCB11 (0.42) | ABCB11POLA1POLGFAPSLC22A6 | |
| SCHEMBL4422979 | 0.88 | ABCB11 (0.36) | ABCB11POLA1POLGFAPSLC22A6 | |
| Maleic Acid SCHEMBL4395451 | 0.86 | FAP (0.40) | ABCB11POLA1POLGFAPSLC22A6 | |
| Malic Acid SCHEMBL27872847 | 0.84 | ABCB11 (0.38) | ABCB11POLA1POLGFAPSLC22A6 | |
| Lb80380 SCHEMBL4270816 | 0.83 | FAP (0.46) | ABCB11POLA1POLGFAPSLC22A6 | |
| Lb80380 SCHEMBL29355183 | 0.83 | FAP (0.46) | ABCB11POLA1POLGFAPSLC22A6 | |
| SCHEMBL2912357 | 0.81 | ABCB11 (0.42) | ABCB11POLA1POLGFAPSLC22A6 | |
| SCHEMBL2939529 | 0.81 | ABCB11 (0.40) | ABCB11POLA1POLGFAPSLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090325904-A1 | MALEIC ACID MONOSALT OF ANTIVIRAL AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | LG LIFE SCIENCES LTD. (KR) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325904-A1 | MALEIC ACID MONOSALT OF ANTIVIRAL AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | MPST, GART, DIMT1 | ABCB11 3730/4885POLA1 637/4885POLG 685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.